These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lanthanum carbonate delays progression of coronary artery calcification compared with calcium-based phosphate binders in patients on hemodialysis: a pilot study. Ohtake T, Kobayashi S, Oka M, Furuya R, Iwagami M, Tsutsumi D, Mochida Y, Maesato K, Ishioka K, Moriya H, Hidaka S. J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):439-46. PubMed ID: 23615577 [Abstract] [Full Text] [Related]
3. Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trial. Toussaint ND, Lau KK, Polkinghorne KR, Kerr PG. Nephrology (Carlton); 2011 Mar; 16(3):290-8. PubMed ID: 21342323 [Abstract] [Full Text] [Related]
4. Evaluation of aortic calcification with lanthanum carbonate vs. calcium-based phosphate binders in maintenance hemodialysis patients with type 2 diabetes mellitus: an open-label randomized controlled trial. Wada K, Wada Y. Ther Apher Dial; 2014 Aug; 18(4):353-60. PubMed ID: 24417760 [Abstract] [Full Text] [Related]
5. The relationship between coronary artery calcification and bone metabolic markers in maintenance hemodialysis patients. Xiong L, Chen QQ, Cheng Y, Lan YS, Yang JB, Wen XQ, Xie X, Kang T, Wu WH, Ou S. BMC Nephrol; 2023 Aug 15; 24(1):238. PubMed ID: 37582785 [Abstract] [Full Text] [Related]
6. Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients. Chang YM, Tsai SC, Shiao CC, Liou HH, Yang CL, Tung NY, Hsu KS, Chen IL, Liu MC, Kao JL, Jhen RN, Huang YT. Clin Exp Nephrol; 2017 Oct 15; 21(5):908-916. PubMed ID: 27928636 [Abstract] [Full Text] [Related]
7. Effect of lanthanum carbonate vs. calcium carbonate on serum calcium in hemodialysis patients: a crossover study. Toida T, Fukudome K, Fujimoto S, Yamada K, Sato Y, Chiyotanda S, Kitamura K. Clin Nephrol; 2012 Sep 15; 78(3):216-23. PubMed ID: 22874110 [Abstract] [Full Text] [Related]
8. Effects of lanthanum carbonate on bone markers and bone mineral density in incident hemodialysis patients. Goto K, Goto S, Fujii H, Watanabe K, Kono K, Nishi S. J Bone Miner Metab; 2019 Nov 15; 37(6):1075-1082. PubMed ID: 31214836 [Abstract] [Full Text] [Related]
11. Effects of Lanthanum Carbonate on Coronary Artery Calcification and Cardiac Abnormalities After Initiating Hemodialysis. Fujii H, Kono K, Nakai K, Goto S, Nishii T, Kono A, Nishi S. Calcif Tissue Int; 2018 Mar 15; 102(3):310-320. PubMed ID: 29058057 [Abstract] [Full Text] [Related]
12. Efficacy and safety of lanthanum carbonate on chronic kidney disease-mineral and bone disorder in dialysis patients: a systematic review. Zhang C, Wen J, Li Z, Fan J. BMC Nephrol; 2013 Oct 17; 14():226. PubMed ID: 24134531 [Abstract] [Full Text] [Related]
13. Effect of calcium carbonate combined with calcitonin on hypercalcemia in hemodialysis patients. Wei Y, Kong XL, Li WB, Wang ZS. Ther Apher Dial; 2014 Dec 17; 18(6):618-22. PubMed ID: 24674384 [Abstract] [Full Text] [Related]
14. Comparison of the effects of lanthanum carbonate and calcium carbonate on the progression of cardiac valvular calcification after initiation of hemodialysis. Watanabe K, Fujii H, Kono K, Goto S, Nishi S. BMC Cardiovasc Disord; 2020 Jan 30; 20(1):39. PubMed ID: 32000687 [Abstract] [Full Text] [Related]
15. Restoration of parathyroid function after change of phosphate binder from calcium carbonate to lanthanum carbonate in hemodialysis patients with suppressed serum parathyroid hormone. Inaba M, Okuno S, Nagayama H, Yamada S, Ishimura E, Imanishi Y, Shoji S. J Ren Nutr; 2015 Mar 30; 25(2):242-6. PubMed ID: 25556148 [Abstract] [Full Text] [Related]
16. Dissociation between progression of coronary artery calcification and endothelial function in hemodialysis patients: a prospective pilot study. Kalil RS, Flanigan M, Stanford W, Haynes WG. Clin Nephrol; 2012 Jul 30; 78(1):1-9. PubMed ID: 22732331 [Abstract] [Full Text] [Related]
17. Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD. Jovanovich A, Isakova T, Block G, Stubbs J, Smits G, Chonchol M, Miyazaki M. Am J Kidney Dis; 2018 Jan 30; 71(1):27-34. PubMed ID: 28801122 [Abstract] [Full Text] [Related]
18. Association of mineral content outside of bone with coronary artery calcium and 1-year cardiovascular prognosis in maintenance hemodialysis patients. Xiong Y, Li J, Sun S, Han M, Liao R, Li Y, Wang L, Lin L, Liu Q, Su B. Artif Organs; 2019 Oct 30; 43(10):988-1001. PubMed ID: 30932185 [Abstract] [Full Text] [Related]
19. Effects of lanthanum carbonate and calcium carbonate on cardiovascular calcification in hemodialysis patients: A systematic review and meta-analysis. Yang J, Zhang X, Wang L. Clin Nephrol; 2022 Jan 30; 97(1):18-26. PubMed ID: 34448696 [Abstract] [Full Text] [Related]
20. A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients. D'Haese PC, Spasovski GB, Sikole A, Hutchison A, Freemont TJ, Sulkova S, Swanepoel C, Pejanovic S, Djukanovic L, Balducci A, Coen G, Sulowicz W, Ferreira A, Torres A, Curic S, Popovic M, Dimkovic N, De Broe ME. Kidney Int Suppl; 2003 Jun 30; (85):S73-8. PubMed ID: 12753271 [Abstract] [Full Text] [Related] Page: [Next] [New Search]